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Sequence analysis of an 850-bp fragment internal to the aspecific drug efflux gene adeB revealed 11 sequence
types (STs) among a collection of 50 multidrug-resistant Acinetobacter baumannii (MDRAB) strains, including
members of pan-European clones I, II, and III. The delineation of STs conformed with the intraspecific
grouping of these strains previously determined by different DNA fingerprinting methods. Larger strain
collections need to be screened to further explore the potential of sequence-based adeB typing as a universal
tool for the monitoring of MDRAB clones.
Acinetobacter baumannii is one of the most frequently iso-
lated nonfermentative gram-negative species from critically ill
and immunocompromised patients among intensive care units
patients worldwide. Strains of this opportunistic pathogen can
be involved in a range of nosocomial infections, such as ven-
tilator-associated pneumonia, bloodstream infections, and
meningitis (1), and are acquiring resistance to multiple antibi-
otics at an increasing rate (4, 9). A. baumannii infections can
occur as sporadic cases associated with single genotypes but
can also give rise to epidemic outbreaks caused by genotypi-
cally highly related isolates, such as those belonging to the
pan-European (pE) multidrug-resistant A. baumannii (MDRAB)
clones I, II, and III (3, 18). Thus far, the intraspecific differ-
entiation of MDRAB has mainly relied on the single or com-
bined use of DNA fingerprinting methods, including ribotyp-
ing, amplified fragment length polymorphism (AFLP) analysis,
pulsed-field gel electrophoresis (PFGE) of macrorestriction
fragments, and repetitive DNA element PCR (rep-PCR) (2, 3,
7, 8, 13, 18). Apart from differences in genotypic resolution,
labor intensity, and reproducibility, all these techniques share
the major drawback that interlaboratory comparison remains
problematic because fingerprinting data are generally not por-
table. DNA sequence-based methods, on the other hand, fa-
cilitate unambiguous and global comparisons of the findings
between different laboratories and are expected to outcompete
banding pattern-based methods in long-term epidemiological
studies (17). As opposed to other human pathogens, however,
the search for genes that can be used in single or multilocus
sequence typing (MLST; http://www.mlst.net) at the intraspe-
cific or strain level is ongoing for A. baumannii. In previous
papers (7, 8, 15), we reported that members of pan-European
MDRAB clones I, II, and III as well as a number of genotyp-
ically unrelated MDRAB strains all shared the aspecific drug
efflux gene adeB, together with various combinations of genes
that specifically confer resistance to aminoglycosides (AGs)
and tetracyclines. The adeB gene makes up part of the adeABC
gene cluster, which encodes a resistance-nodulation-cell divi-
sion-type three-component efflux system that was recently de-
scribed for A. baumannii strain BM4454 (10). In this strain,
adeABC conferred low-level resistance to several aminoglyco-
sides and reduced susceptibilities to various other antimicro-
bial agents. Triggered by the observation that the adeB gene
was present in a set of genotypically related and unrelated
MDRAB strains from different geographical origins and time
periods, the current study set out to investigate whether adeB
is a suitable locus for sequence-based identification of in-
traspecific groups among MDRAB strains.
For the purpose of this study, 50 well-documented MDRAB
strains mostly from European hospitals were selected from
previous studies in which they were typed by one or multiple
DNA fingerprinting methods and in which it was shown that
they contained the adeB gene (Table 1). This selection in-
cluded members of pE clones I, II, and III but also clinical
strains from the Czech Republic previously allocated to three
ribotypes, five genotypically unrelated clinical strains, and vet-
erinary isolate LMG 22458. Most of the MDRAB selected
strains were resistant to one or multiple aminoglycosides (Ta-
ble 1), to several fluoroquinolones (18), and to tetracycline (7,
8). Susceptibility to aminoglycosides was determined by the
disk diffusion method with BBL Mueller-Hinton II agar (Bec-
ton Dickinson and Company), according to the recommenda-
tions of CLSI (formerly NCCLS) (12), by using the following
disks (Oxoid Ltd., Basingstoke, United Kingdom): kanamycin
(30 g), gentamicin (10 g), tobramycin (10 g), amikacin (30
g), and netilmicin (30 g). Total genomic DNA was prepared
by using a protocol based on the method of Pitcher and co-
workers (16). For adeB detection, a common PCR core mix
(total volume, 50 l) was used that consisted of 1 PCR buffer
(Applied Biosystems, Warrington, United Kingdom), de-
oxynucleoside triphosphates (dNTPs; Applied Biosystems) at a
concentration of 200 M of each dNTP, 1 U of AmpliTaq
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DNA polymerase (Applied Biosystems), and 20 pmol of each
primer (Sigma-Genosys Ltd., Cambridgeshire, United King-
dom). A 50-ng portion of intact total DNA was used as the
PCR template. Detection and partial sequence analysis of
adeB were performed with the previously published PCR
primer pair O3 (5-GTATGAATTGATGCTGC-3) and O4
(5-CACTCGTAGCCAATACC-3) that targets a 979-bp frag-
ment internal to this gene in A. baumannii strain BM4454,
which was used as a positive control in PCR (10). PCR ampli-
fications were performed in a GeneAmp 9600 PCR system
(Perkin-Elmer) by using the following temperature program:
initial denaturation at 94°C for 5 min; 25 cycles of denaturation
at 94°C for 30 s, annealing at 55°C for 1 min, and extension at
72°C for 1 min; and a final extension at 72°C for 7 min. Partial
sequencing of adeB positions 1635 to 2484 was performed by
using the BigDye Terminator (version 3.1) ready reaction cycle
sequencing kit on an ABI Prism 3100 genetic analyzer (Ap-
plied Biosystems). As a control, the sequence of the internal
adeB fragment of A. baumannii strain BM4454 (EMBL acces-
sion no. AF370885) (10) was redetermined. Sequence align-
ments and comparisons were performed by using BioNumerics
software (version 3.5; Applied Maths, St.-Martens Latem, Bel-
gium) and the BioEditor program (5).
In the present study, the previously designed primer pair
O3-O4 (10) was used for sequence analysis of an internal
region of the adeB gene in order to investigate whether this
gene contains polymorphic sites that are potentially useful for
sequence-based identification of intraspecific groups in
MDRAB. As a result of this partial sequencing approach, 11
different adeB sequence types (STs; STs I to XI) could be
defined (Fig. 1) among a collection of 50 MDRAB strains
representing six previously delineated intraspecific groups and
five genotypically unrelated strains. By definition, an adeB
gene was considered to represent a distinct ST when its 850-bp
partial sequence differed in at least one position from all other
sequences. STs that were shared by two or more strains (i.e.,
STs I to VI) all displayed a complete internal sequence iden-
tity, whereas the number of base conversions between individ-
ual STs ranged from 2 to 45 (Fig. 1). Although the majority of
these conversions were found to represent silent mutations, a
number of substitutions resulted in amino acid sequence poly-
morphisms (Table 2). The polymorphic sites at positions 551,
584, 606, and 730 may be of diagnostic value for discrimination
of pE clones I, II, and III; but clearly, more strains of these
intraspecific MDRAB groups need to be investigated to verify
this finding. The partially redetermined nucleotide sequence of
the adeB gene of strain BM4454 (10) differed from the original
sequence (EMBL accession no. AF370885) at two positions,
FIG. 1. Unrooted maximum-parsimony tree of multiple aligned partial adeB sequences representing 11 STs, indicated by capital Roman letters
I to XI followed by the EMBL accession number in parentheses. The number of base conversions over the tree is indicated along the phylogenetic
distance lines, and bootstrap percentages are indicated in parentheses for analysis of 100 replicates.
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i.e., positions 1974 and 2295, where in both cases the sequence
representing ST II (EMBL accession no. AJ971416) contained
an A instead of a G.
The delineation of the 11 adeB STs completely agreed with
the intraspecific diversity among the 50 MDRAB strains pre-
viously assessed by DNA fingerprinting methods such as ri-
botyping, AFLP analysis, PFGE, and/or rep-PCR. The most
remarkable finding was that all members of pE clones I (n 
16), II (n  13), and III (n  10) belonged to the same adeB
ST, i.e., STs I, II, and III, respectively (Table 1). The strains of
pE clones I, II, and III included for this study were selected in
a way that they represented hospital units from four to six
different European countries and that they were isolated at
different time points during the past 20 years. The fact that
members of a given pE clone with different geographical
and/or temporal histories all shared the same adeB ST thus
indicates that sequence-based typing of this gene may be a
potential tool for the quick identification of new members of
these widespread clones. As evidenced by the data obtained
with the Czech MDRAB strains previously allocated to Hin-
dIII-HincII ribotyping groups R21-16 and R23-19 and, accord-
ingly, also grouped in two AFLP clusters (13) (Table 1), partial
adeB sequencing may also have the potential to identify less
widespread intraspecific MDRAB groups. The two represen-
tative strains of both groups displayed an identical adeB ST;
and the two corresponding STs, STs V and VI, appeared to be
unique and clearly distinct from STs I to III (Fig. 1). Interest-
ingly, strains NIPH 1717 and NIPH 301, which were previously
assigned to the highly related ribotypes R2–6 and R2–7 and
that grouped in the same AFLP cluster (13), were also joined
together by adeB typing as members of ST IV (Table 1). The
finding that the five genotypically unrelated MDRAB strains
from the Czech Republic, the United Kingdom, and Brazil
(Table 1) each exhibited a unique adeB ST may indicate that
these strains represent distinct intraspecific lineages in A. bau-
mannii (Fig. 1); but further evidence, e.g., evidence based on
MLST, is awaited to substantiate this. The fact that strains AC
658 and NIPH 1734, which represent the closely related adeB
STs IX and X (Fig. 1), respectively, also displayed highly sim-
ilar but not identical (GTG)5-PCR band patterns (G. Huys,
unpublished data) again illustrates the good overall agreement
found between the adeB sequence-based grouping and the
intraspecific grouping based on DNA fingerprinting. On the
other hand, our sequencing data also indicate that the 850-bp
region of the adeB gene analyzed in this study is probably not
variable enough to discriminate MDRAB strains at the sub-
clonal level. For example, clone II strains NIPH 1469 and
RUH 3240 shared a ribotype (ribotype R4-2) slightly different
from the other clone II ribotypes and grouped in a distinct
AFLP subcluster of clone II (13), and yet, both strains be-
longed to ST II (Table 1). Possibly, sequencing of longer or
multiple fragments of adeB or other components of the ad-
eABC gene cluster may increase the resolution of the method.
At present, little is known about the distribution and evolu-
tionary history of the adeB gene in A. baumannii. So far, the
gene has mainly been detected in A. baumannii outbreak
strains (6, 7, 8) that exhibit resistance to multiple drugs, usually
including one or more AGs. Recently, it was found that adeB
can be up-regulated in MDRAB (6) and that it can also occur
in drug-susceptible A. baumannii strains (15), in which the
gene may be cryptic due to the regulatory control by the two-
component AdeRS system (11). Because of this stringent con-
trol, it is difficult to predict the presence of adeB in A. bau-
mannii based on the AG resistance profile. In addition, many
European MDRAB strains are known to carry one or several
specific AG resistance genes (14) that can potentially reinforce
the AG resistance spectrum encoded by adeB. This effect is
highly pronounced for pE clones I and II, in which the AG
resistotypes differed significantly among adeB-positive strains
(Table 1). In the course of a PCR-based screening survey for
adeB in 32 environmental A. baumannii isolates of aquatic and
terrestrial origins, it was found that none of the strains inves-
tigated harbored the efflux gene (Huys, unpublished). Provided
that the use of additional (degenerated) primer sets confirm
these findings, this suggests that the gene is probably not om-
nipresent in A. baumannii and was acquired by a number of
strains from an exogenous source at some point in time. For
this reason, it is expected that adeB typing will primarily be
useful for clinical isolates of this species.
Based on partial sequencing analysis, the present study has
demonstrated that the delineation of adeB STs among geno-
typically related and unrelated MDRAB strains corroborated
extremely well the genotypic clustering of these strains previ-
ously obtained with various banding pattern-based methods.
However, it is clear that more extended collections of clinical
and environmental isolates need to be investigated in order to
obtain better insight into the distribution of the adeB gene
among A. baumannii strains and to further validate the use of
adeB typing for the rapid identification of known intraspecific
groups or the delineation of new intraspecific lineages in this
species. When it is integrated in a dynamic Internet-based
platform, sequence-based typing of adeB could prove to be a
useful tool for worldwide monitoring of MDRAB clones.
Nucleotide sequence accession numbers. A selection of the
sequences representing the 11 adeB sequence types reported in
this study have been submitted to EMBL under accession
numbers AJ971415 to AJ971425 (Fig. 1).
TABLE 2. Polymorphic amino acid positions for 11 adeB STs
in A. baumannii
adeB ST
Amino acid at the following polymorphic amino acid positiona:
551 584 606 642 645 660 730 768
I A T A D S P L A
II T T T D S P F A
III A I T D S P L A
IV A T T A T P L A
V A T T A T Q L A
VI A T T D S P L A
VII A T T D T P L T
VIII A T T A T P L A
IX A T T A T P L A
X A T T A T P L A
XI A T T D T P L A
a Aligned nucleotide sequences of partial adeB fragments (positions 1635 to
2484 according to the numbering of the adeB sequence with EMBL accession no.
AF370885) were translated into amino acid sequences by using a polymorphism
statistics tool in Bionumerics. Polymorphic amino acid positions were identified
with the BioEdit sequence alignment editor.
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